All News
Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC
(MedPage Today) -- When Matt was diagnosed with ALK-positive (ALK+) metastatic non-small cell lung cancer (mNSCLC), his world turned upside down.
Read MoreI Am Torn: Grappling With the Killing of UnitedHealthcare's CEO
(MedPage Today) -- I am torn.
Read MoreSTAT+: Budget negotiations heat up as ACA subsidy extension, BIOSECURE get dropped
The latest in policy and public health: Federal budget talks are heating up, pharma isn't opposing RFK Jr., and a vaccine news update.
Read MoreSTAT+: Stem cell transplant not needed for most mantle cell lymphoma patients, study suggests
The "sledgehammer-like treatment" of stem cell transplants had no benefit for most mantle cell lymphoma patients, according to study reported at ASH.
Read MoreEmpathetic Phone Calls Help Vulnerable Diabetes Patients Lower HbA1c
(MedPage Today) -- Empathy-oriented phone calls from laypersons helped patients with uncontrolled diabetes improve glycemic control, a parallel-arm superiority trial found.
Read MoreAI Screening of Home Videos Proves Accurate for Infantile Seizure Detection
(MedPage Today) -- LOS ANGELES -- An artificial intelligence (AI) model accurately detected and ruled out infantile epileptic spasm syndrome in videos captured by family, a study showed.
Read MoreOpinion: Jamie Foxx calls on the Senate to pass a bill funding Down syndrome research
Jamie Foxx and the president of the GLOBAL Down Syndrome Foundation have teamed up to push the Senate to pass a bill named in honor of Jamie’s late sister.
Read MoreHealth Panel Endorses New Option for Cervical Cancer Screening
Starting at 30, women can collect their own vaginal samples for HPV testing at a doctor’s office.
Read MoreResearchers are betting on cockroaches as the cure to elitism in neuroscience
Cockroaches are a hardy pest, and often elicit disgust.
Read MoreNovel Drug Fails for Two Rare Seizure Disorders
(MedPage Today) -- LOS ANGELES -- The novel agent soticlestat flopped in a pair of phase III trials for rare seizure disorders, researchers reported here.
Read More